"Schlesinger Group is a global marketing research supplier offering qualitative and quantitative data collection, in-person, on the phone, or online."

During the past decade, Schlesinger Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Schlesinger Associates" are "Needle Stick" (2 trials). Many other conditions were trialed in "Schlesinger Associates" in a lesser frequency.

Most popular intervention types in "Schlesinger Associates" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Acti-Lance safety lancet" (1 trials), "Haemolance Plus safety lancet" (1 trials), "MediSafe Solo safety lancet" (1 trials), "Prolance safety lancet" (1 trials) and "ergoLance safety lancet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Schlesinger Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Schlesinger Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Schlesinger Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Schlesinger Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".